Integr Cancer Ther. 2006 Mar;5(1):83-9.

The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.

Source

Integrative Medical Center of New Mexico and New Mexico State University, Las Cruces.

Abstract

The authors describe the long-term survival of a patient with pancreatic cancer without any toxic adverse effects. The treatment regimen includes the intravenous alpha-lipoic acid and low-dose naltrexone (ALA-N) protocol and a healthy lifestyle program. The patient was told by a reputable university oncology center in October 2002 that there was little hope for his survival. Today, January 2006, however, he is back at work, free from symptoms, and without appreciable progression of his malignancy. The integrative protocol described in this article may have the possibility of extending the life of a patient who would be customarily considered to be terminal. The authors believe that life scientists will one day develop a cure for metastatic pancreatic cancer, perhaps via gene therapy or another biological platform. But until such protocols come to market, the ALA-N protocol should be studied and considered, given its lack of toxicity at levels reported. Several other patients are on this treatment protocol and appear to be doing well at this time.

PMID:: 16484716; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

NALTREXONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases. [Integr Cancer Ther. 2009]
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
Berkson BM, Rubin DM, Berkson AJ. Integr Cancer Ther. 2009 Dec; 8(4):416-22.
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. [Ann Surg. 2009]
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, et al. Ann Surg. 2009 Jul; 250(1):88-95.
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. [Ann Oncol. 2008]
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.
Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouché O, Bosset JF, Aparicio T, Mineur L, Azzedine A, et al. Ann Oncol. 2008 Sep; 19(9):1592-9. Epub 2008 May 7.
Review The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis. [Rev Esp Enferm Dig. 2009]
Review The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.
Gómez Portilla A, Cendoya I, Olabarría I, Martínez de Lecea C, Gómez Martínez de Lecea C, Gil A, Martín E, Muriel J, Magrach L, Romero E, et al. Rev Esp Enferm Dig. 2009 Feb; 101(2):97-102, 103-6.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.

See reviews... See all...

Cited by 1 PubMed Central article

Review Endogenous opiates and behavior: 2006. [Peptides. 2007]
Review Endogenous opiates and behavior: 2006.
Bodnar RJ. Peptides. 2007 Dec; 28(12):2435-513. Epub 2007 Sep 11.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The long-term survival of a patient with pancreatic cancer with metastases to th...
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
Integr Cancer Ther. 2006 Mar ;5(1):83-9.

PubMed
Osteonecrosis of the jaw in multiple myeloma patients: clinical features and ris...
Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.
J Clin Oncol. 2006 Feb 20 ;24(6):945-52.

PubMed
Infections and airway inflammation in chronic obstructive pulmonary disease seve...
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Am J Respir Crit Care Med. 2006 May 15 ;173(10):1114-21. Epub 2006 Feb 16 .

PubMed
State of the art in research on equity in health.
State of the art in research on equity in health.
J Health Polit Policy Law. 2006 Feb ;31(1):11-32.

PubMed
Garlic and cardiovascular disease: a critical review.
Garlic and cardiovascular disease: a critical review.
J Nutr. 2006 Mar ;136(3 Suppl):736S-740S.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information